| |
| Issue |
Title |
| |
| Vol 3, No 4 (2017) |
Proton therapy – An evolving technology |
Abstract
PDF
|
|
Antonio Cassio Assis Pellizzon |
| |
| Vol 6, No 3 (2020) |
Effect of Herceptin Combined with Phryl on Serum Tumor Markers and Toxicities in Patients with Breast Cancer |
Abstract
PDF
|
|
Shibo Gao |
| |
| Vol 4, No 3 (2018) |
The Role of IL-35 in Regulating Tumor Immunity |
Abstract
PDF
|
|
Junfeng Zhang, Yunsheng Zhang, Chunlei Li, Xiaomei Zhang, Huabao Xiong, Hongxin Deng |
| |
| Vol 2, No 4 (2016) |
Breast cancer metastases to the stomach and colon mimicking primary gastrointestinal cancer: Four cases and literature review |
Abstract
PDF
|
|
Necdet Uskent, Hüseyin Baloğlu, Metin Çakmakçı, Sezer Saglam, Ulkuhan Koksal |
| |
| Vol 5, No 4 (2019) |
Study on the Correlation between the Detection of Tumor Markers in Abdominal Effusion and Chemotherapy Sensitivity |
Abstract
PDF
|
|
Martin Gummert, Namshin Kim |
| |
| Vol 3, No 6 (2017) |
Contribution of germline TP53 variants and assessment of HER-2 status among young breast cancer patients in Malaysia |
Abstract
PDF
|
|
Shao Yan Lau, Pei Sze Ng, Joanna Lim, Wei Xiong Wen, Kah Nyin Lai, Siti Norhidyu Hasan, Daphne Shin-Chin Lee, Sook Yee Yoon, Cheng Har Yip, Nur Aishah Mohd Taib, Antonis Antoniou, Alison Dunning, Douglas Easton, Soo Hwang Teo |
| |
| Vol 3, No 3 (2017) |
A quantitative comparison of gross tumor volumes delineated on [18F]-FDG-PET/CT scan and contrast-enhanced computed tomography scan in locally advanced head and neck carcinoma treated with Intensity Modulated Radiotherapy |
Abstract
PDF
|
|
Nagarjuna Burela, Tej Prakash Soni, Nidhi Patni, JK Bhagat, T Senthil Kumar, Thiru Natarajan |
| |
| Vol 6, No 3 (2020) |
Effect of Docetaxel and Cisplatin Chemotherapy Combined with Intensity-modulated Radiotherapy in the Treatment of Postoperative Recurrence of Esophageal Cancer and Its Effect on Serum Tumor Markers |
Abstract
PDF
|
|
Tianliang Zhao, Weinian Kang |
| |
| Vol 4, No 3 (2018) |
Report of Cancer Incidence and Mortality in China, 2012 |
Abstract
PDF
|
|
Yuanqing Zhang, Tianlong Zheng, Wude Zhang |
| |
| Vol 2, No 4 (2016) |
Analysis on misdiagnosed cases of right colon cancer as appendicitis |
Abstract
PDF
|
|
Sijia Liu |
| |
| Vol 2, No 1 (2016) |
Lysophosphatidic acid receptor isoforms expression in prostate cancer cells is differentially regulated by the CYP17A1 inhibitor abiraterone and depends on the androgen receptor |
Abstract
PDF
|
|
Matthias S Stope, Robert Mandelkow, Daniela Brunnert, Martin Weiss, Martin Burchardt |
| |
| Vol 3, No 3 (2017) |
Identification and verification of a pathogenic MLH1 mutation c.1145dupA in a Lynch syndrome family |
Abstract
PDF
|
|
Huang Feifei, Tao Xiang, Jiang Wei, Chen Jun, Feng Weiwei |
| |
| Vol 6, No 3 (2020) |
Diagnostic Value of Tumor Markers CA153 and CA125 in Breast Cancer |
Abstract
PDF
|
|
Yuxia Sun |
| |
| Vol 2, No 4 (2016) |
IGF-I biomarker testing in an ethical context |
Abstract
PDF
|
|
Annabelle Trojan, Beatriz H. Aristizabal, Lina M. Jay, Tatiana Castillo, Pedro J. Penagos, Ignacio Briceño, Jerzy Trojan |
| |
| Vol 5, No 3 (2019) |
Effects of Neoadjuvant Chemotherapy on Multiple Cytokines in Patients with Tri-negative Breast Cancer |
Abstract
PDF
|
|
Adam R Botha |
| |
| Vol 3, No 6 (2017) |
Protocol for the mainstreaming genetic counselling for genetic testing of BRCA1 and BRCA2 in ovarian cancer patients in Malaysia (MaGiC study) |
Abstract
PDF
|
|
Nor Syuhada Ahmad Bashah, Yin Leng Woo, Joanna Lim, Meow Keong Thong, Soo Hwang Teo, MaGiC Investigators, Sook Yee Yoon |
| |
| Vol 2, No 1 (2016) |
Pharmacometrics and systems pharmacology of immune checkpoint inhibitor nivolumab in cancer translational medicine |
Abstract
PDF
|
|
Sujit Nair |
| |
| Vol 3, No 3 (2017) |
Pharmacokinetics and systems pharmacology of monoclonal antibody olaratumab for inoperable soft tissue sarcoma |
Abstract
PDF
|
|
Sujit Nair, Akshay Iyer, Vishnu Vijay, Sairam Bandlamudi, Adrián Llerena |
| |
| Vol 4, No 1 (2018) |
Optimizing treatment-sequencing strategies for the management of postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer: A Malaysian perspective |
Abstract
PDF
|
|
Ahmad Radzi, Fabian Wei Luen Lee |
| |
| Vol 2, No 3 (2016) |
KRAS as a prognostic marker for metastatic colorectal cancer: Qatar experience |
Abstract
PDF
|
|
Kakil I Rasul, Hind Elmalik, Mini Satheesh, Prem Chandra |
| |
| Vol 2, No 1 (2016) |
Personalized hormonal treatment for prostate cancer: An opportunity for improvement |
Abstract
PDF
|
|
Omar Abdel-Rahman |
| |
| Vol 4, No 6 (2018) |
The testis: an accessible Mesenchymal Stem Cells source |
Abstract
PDF
|
|
Myret Ghabriel, Asma Amleh |
| |
| Vol 3, No 3 (2017) |
Significance of defining a pathogenic variant in hereditary cancer syndrome |
Abstract
PDF
|
|
Kwong-Kwok Wong |
| |
| Vol 3, No 6 (2017) |
Clinical applicability and feasibility of the revised cancer notification form in Johor |
Abstract
PDF
|
|
Nurul Huda Binti Razali, Nurul Atikah Binti Mohd Salleh, Sunitha A/P Kumaran, Badrul Zaman Bin Muda, Mohd Roslan Bin Haron |
| |
| Vol 2, No 3 (2016) |
The war against cancer: Suicide gene therapy |
Abstract
PDF
|
|
Muzeyyen Izmirli, Dilara Sonmez, Bulent Gogebakan |
| |
| 51 - 75 of 100 Items |
<< < 1 2 3 4 > >> |
